Cleared Traditional

K022581 - BECTON DICKINSON LOGIC BLOOD GLUCOSE MO...

K022581 is an FDA 510(k) clearance for BECTON DICKINSON LOGIC BLOOD GLUCOSE MO..., manufactured by Becton, Dickinson & CO. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 65-day FDA review.

K022581 · Becton, Dickinson & CO · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2002
Decision
65d
Days
Class 2
Risk

K022581 is an FDA 510(k) clearance for the BECTON DICKINSON LOGIC BLOOD GLUCOSE MONITORING SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Becton, Dickinson & CO (Franklin Lakes, US). The FDA issued a Cleared decision on October 9, 2002 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton, Dickinson & CO devices

FDA 510(k) Submission Details - K022581

510(k) Number K022581 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2002
Decision Date October 09, 2002
Days to Decision 65 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 88d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 266
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K022581.
SURESTEP HOSPITAL BLOOD GLUCOSE MONITORING SYSTEM
K023832 · Lifescan, Inc. · Dec 2002
BECTON DICKINSON DIABETES SOFTWARE
K023219 · Becton, Dickinson & CO · Dec 2002
ASCENSIA DEX 2 DIABETES CARE SYSTEM
K023584 · Bayer Corp. · Nov 2002
SURESTEP BLOOD GLUCOSE MONITORING SYSTEM
K022724 · Lifescan, Inc. · Sep 2002
MEDISENSE PRECISION EASYBLOOD GLUCOSE MONITORING SYSTEM, MEDISENSE OPTIUM EASYBLOOD GLUCOSE MONITORING SYSTEM
K022182 · Abbott Laboratories · Sep 2002
ONE TOUCH ULTRASMART BLOOD GLUCOSE MONITORING SYSTEM
K021819 · Lifescan, Inc. · Aug 2002